Moderna asks Health Canada to authorize COVID-19 vaccine for young children
Approval would affect children aged six months to five years
Health Canada has received an application from Moderna to authorize use of its COVID-19 Spikevax vaccine in young children.
The application was received Friday, according to the Health Canada website, and would affect children between the ages of six months to five years. Currently, children under five years old aren’t eligible for COVID-19 vaccination.
The company applied for emergency use authorization for young children in the U.S. this week as well.
Nunavut and Nunavik rolled out vaccines for children aged five to 11 in November.
Canada is in the midst of yet another wave of the COVID-19 pandemic. Meanwhile, most jurisdictions have stopped tracking cases and nearly all COVID-19 related restrictions across the country have been lifted.
Health Canada did not immediately respond to questions regarding how long it might take the department to review the application, and there is no indication on when it could roll out upon approval.